2025-02-122026-03-272025-02-12202310.1002/14651858.CD014670https://doi.org/10.1002/14651858.CD014670https://repositorio.inprf.gob.mx/handle/123456789/8213Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy and tolerability of aripiprazole compared to brexpiprazole in people diagnosed with schizophrenia or schizophrenia‐like psychosis.PDFengAcceso CerradoProtocol - Intervention1469-493XInstituto Nacional de Psiquiatría Ramón de la Fuente MuñizInglaterraInglaterra